Obesity and diabetes are known risk factors for
dementia, and it is speculated that chronic
neuroinflammation contributes to this increased risk. Microglia are brain-resident immune cells modulating the neuroinflammatory state.
Eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA), the major ω-3
polyunsaturated fatty acids (PUFAs) of
fish oil, exhibit various effects, which include shifting microglia to the anti-inflammatory phenotype. To identify the molecular mechanisms involved, we examined the impact of EPA, DHA, and EPA+DHA on the
lipopolysaccharide (LPS)-induced
cytokine profiles and the associated signaling pathways in the mouse microglial line MG6. Both EPA and DHA suppressed the production of the pro-inflammatory
cytokines TNF-α and
IL-6 by LPS-stimulated MG6 cells, and this was also observed in LPS-stimulated BV-2 cells, the other microglial line. Moreover, the EPA+DHA mixture activated
SIRT1 signaling by enhancing
mRNA level of
nicotinamide phosphoribosyltransferase (NAMPT), cellular NAD+ level,
SIRT1 protein deacetylase activity, and
SIRT1 mRNA levels in LPS-stimulated MG6. EPA+DHA also inhibited phosphorylation of the stress-associated
transcription factor NF-κB subunit p65 at Ser536, which is known to enhance NF-κB nuclear translocation and transcriptional activity, including
cytokine gene activation. Further, EPA+DHA increased the LC3-II/LC3-I ratio, an
indicator of autophagy. Suppression of TNF-α and
IL-6 production, inhibition of p65 phosphorylation, and autophagy induction were abrogated by a
SIRT1 inhibitor. On the other hand, NAMPT inhibition reversed TNF-α suppression but not
IL-6 suppression. Accordingly, these ω-3 PUFAs may suppress
neuroinflammation through SIRT1-mediated inhibition of the microglial NF-κB stress response and ensue pro-inflammatory
cytokine release, which is implicated in NAMPT-related and -unrelated pathways.